OR WAIT 15 SECS
© 2020 MJH Life Sciences and Contemporary OB/GYN. All rights reserved.
© 2020 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
GSM can be clinically detected in up to 90% of postmenopausal women undergoing evaluation but only one-third report vulvovaginal symptoms when surveyed.
Despite the prevalence of GSM, the condition continues to be under-recognized and undertreated due to a combination of patient and provider factors. Providers need to take the initiative in screening and patient education.